MOTS-c
Prescription OnlyOverview
MOTS-c is a mitochondrial-derived peptide encoded within the 12S rRNA gene. It is an emerging peptide in the Australian market with limited prescriber familiarity. Not yet widely compounded, but interest is growing.
Australian Scheduling
Schedule 4 (Prescription Only). TGA is monitoring this peptide as its use grows. Limited compounding infrastructure currently in place.
Access Pathway
Available through a small number of telehealth providers. 4 identified Australian providers. Prescriber familiarity is limited, and not all compounding pharmacies have established formulations.
For informational purposes only. TGA scheduling may change without notice. All Schedule 4 peptides require a valid prescription from a registered Australian medical practitioner. This site does not sell, supply, or facilitate access to therapeutic goods. Data compiled from TGA SUSMP, public provider directories, and publicly available review platforms.